A case of hepatocarcinoma preceded by several years by "isolated" increase in alphafetoprotein
Hepatocarcinoma (HCC), the most frequent malignant hepatic neoplasia, is sometimes difficult to diagnose at an early stage since the symptoms may be attributed to concomitant hepatic cirrhosis. The assay of alpha-fetoprotein associated with an ultrasound examination of the hepatic parenchyma is an important screening tool for high-risk patients. Ultrasound examination is considered the most sensitive method and alpha-fetoprotein is a supplementary diagnostic tool. Elevated alpha-fetoprotein only occasionally precedes morphological anomalies and even in these cases the neoplastic aspect emerges within a short period of time. The case reported here illustrates the "astronomic" increase of alpha-fetoprotein in a high-risk patient for HCC (positive HBsAg cirrhosis) without the manifest appearance of any instrumental or histological data confirming the presence of the tumour for two years. When the tumour was identified in instrumental tests it had spread throughout the entire hepatic parenchyma in a form which could no longer be treated using any form of therapy. The case reported here emphasizes the diagnostic value of alphafetoprotein in high-risk patients for HCC, even in the prolonged absence of all other data regarding neoplastic transformation.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1992 |
|---|---|
| Erschienen: |
1992 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Minerva gastroenterologica e dietologica - 38(1992), 3 vom: 01. Juli, Seite 167-9 |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
Un caso di epatocarcinoma preceduto per anni da aumento "isolato" dell'alfafetoproteina |
|---|
| Beteiligte Personen: |
Durazzo, M [VerfasserIn] |
|---|
| Themen: |
Alpha-Fetoproteins |
|---|
| Anmerkungen: |
Date Completed 20.05.1993 Date Revised 15.11.2006 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM012649414 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM012649414 | ||
| 003 | DE-627 | ||
| 005 | 20231221053206.0 | ||
| 007 | tu | ||
| 008 | 231221s1992 xx ||||| 00| ||ita c | ||
| 028 | 5 | 2 | |a pubmed24n0043.xml |
| 035 | |a (DE-627)NLM012649414 | ||
| 035 | |a (NLM)1284376 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Durazzo, M |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A case of hepatocarcinoma preceded by several years by "isolated" increase in alphafetoprotein |
| 246 | 3 | 3 | |a Un caso di epatocarcinoma preceduto per anni da aumento "isolato" dell'alfafetoproteina |
| 264 | 1 | |c 1992 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 20.05.1993 | ||
| 500 | |a Date Revised 15.11.2006 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Hepatocarcinoma (HCC), the most frequent malignant hepatic neoplasia, is sometimes difficult to diagnose at an early stage since the symptoms may be attributed to concomitant hepatic cirrhosis. The assay of alpha-fetoprotein associated with an ultrasound examination of the hepatic parenchyma is an important screening tool for high-risk patients. Ultrasound examination is considered the most sensitive method and alpha-fetoprotein is a supplementary diagnostic tool. Elevated alpha-fetoprotein only occasionally precedes morphological anomalies and even in these cases the neoplastic aspect emerges within a short period of time. The case reported here illustrates the "astronomic" increase of alpha-fetoprotein in a high-risk patient for HCC (positive HBsAg cirrhosis) without the manifest appearance of any instrumental or histological data confirming the presence of the tumour for two years. When the tumour was identified in instrumental tests it had spread throughout the entire hepatic parenchyma in a form which could no longer be treated using any form of therapy. The case reported here emphasizes the diagnostic value of alphafetoprotein in high-risk patients for HCC, even in the prolonged absence of all other data regarding neoplastic transformation | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a alpha-Fetoproteins |2 NLM | |
| 700 | 1 | |a Borghesio, E |e verfasserin |4 aut | |
| 700 | 1 | |a Regge, D |e verfasserin |4 aut | |
| 700 | 1 | |a Milone, P A |e verfasserin |4 aut | |
| 700 | 1 | |a Rizzetto, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Minerva gastroenterologica e dietologica |d 1996 |g 38(1992), 3 vom: 01. Juli, Seite 167-9 |w (DE-627)NLM012649406 |x 1827-1642 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:1992 |g number:3 |g day:01 |g month:07 |g pages:167-9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 1992 |e 3 |b 01 |c 07 |h 167-9 | ||